Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 3020 entries
Sorted by: Best Match Show Resources per page
The OnTrack Diabetes Web-Based Program for Type 2 Diabetes and Dysphoria Self-Management: A Randomized Controlled Trial Protocol.

JMIR research protocols

Cassimatis M, Kavanagh DJ, Hills AP, Smith AC, Scuffham PA, Gericke C, Parham S.
PMID: 26242916
JMIR Res Protoc. 2015 Aug 04;4(3):e97. doi: 10.2196/resprot.2813.

BACKGROUND: The prevalence of type 2 diabetes is rising with the majority of patients practicing inadequate disease self-management. Depression, anxiety, and diabetes-specific distress present motivational challenges to adequate self-care. Health systems globally struggle to deliver routine services that are...

Cite
Cassimatis M, Kavanagh DJ, Hills AP, et al. The OnTrack Diabetes Web-Based Program for Type 2 Diabetes and Dysphoria Self-Management: A Randomized Controlled Trial Protocol. JMIR Res Protoc. 2015;4(3):e97doi: 10.2196/resprot.2813.
Cassimatis, M., Kavanagh, D. J., Hills, A. P., Smith, A. C., Scuffham, P. A., Gericke, C., & Parham, S. (2015). The OnTrack Diabetes Web-Based Program for Type 2 Diabetes and Dysphoria Self-Management: A Randomized Controlled Trial Protocol. JMIR research protocols, 4(3), e97. https://doi.org/10.2196/resprot.2813
Cassimatis, Mandy, et al. "The OnTrack Diabetes Web-Based Program for Type 2 Diabetes and Dysphoria Self-Management: A Randomized Controlled Trial Protocol." JMIR research protocols vol. 4,3 (2015): e97. doi: https://doi.org/10.2196/resprot.2813
Cassimatis M, Kavanagh DJ, Hills AP, Smith AC, Scuffham PA, Gericke C, Parham S. The OnTrack Diabetes Web-Based Program for Type 2 Diabetes and Dysphoria Self-Management: A Randomized Controlled Trial Protocol. JMIR Res Protoc. 2015 Aug 04;4(3):e97. doi: 10.2196/resprot.2813. PMID: 26242916; PMCID: PMC4705366.
Copy Download .nbib Format: NLM
A Case of Euglycemic Diabetic Ketoacidosis Following Long-term Empagliflozin Therapy.

Diabetes care

Farjo PD, Kidd KM, Reece JL.
PMID: 27436273
Diabetes Care. 2016 Oct;39(10):e165-6. doi: 10.2337/dc16-0728. Epub 2016 Jul 19.

No abstract available.

Cite
Farjo PD, Kidd KM, Reece JL. A Case of Euglycemic Diabetic Ketoacidosis Following Long-term Empagliflozin Therapy. Diabetes Care. 2016;39(10):e165-6doi: 10.2337/dc16-0728.
Farjo, P. D., Kidd, K. M., & Reece, J. L. (2016). A Case of Euglycemic Diabetic Ketoacidosis Following Long-term Empagliflozin Therapy. Diabetes care, 39(10), e165-6. https://doi.org/10.2337/dc16-0728
Farjo, Peter D, et al. "A Case of Euglycemic Diabetic Ketoacidosis Following Long-term Empagliflozin Therapy." Diabetes care vol. 39,10 (2016): e165-6. doi: https://doi.org/10.2337/dc16-0728
Farjo PD, Kidd KM, Reece JL. A Case of Euglycemic Diabetic Ketoacidosis Following Long-term Empagliflozin Therapy. Diabetes Care. 2016 Oct;39(10):e165-6. doi: 10.2337/dc16-0728. Epub 2016 Jul 19. PMID: 27436273.
Copy Download .nbib Format: NLM
Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270.

Diabetes care

Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ.
PMID: 25805866
Diabetes Care. 2015 Apr;38(4):734-5. doi: 10.2337/dc15-er04a.

No abstract available.

Cite
Harding JL, Shaw JE, Peeters A, et al. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270. Diabetes Care. 2015;38(4):734-5doi: 10.2337/dc15-er04a.
Harding, J. L., Shaw, J. E., Peeters, A., Cartensen, B., & Magliano, D. J. (2015). Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270. Diabetes care, 38(4), 734-5. https://doi.org/10.2337/dc15-er04a
Harding, Jessica L, et al. "Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270." Diabetes care vol. 38,4 (2015): 734-5. doi: https://doi.org/10.2337/dc15-er04a
Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270. Diabetes Care. 2015 Apr;38(4):734-5. doi: 10.2337/dc15-er04a. PMID: 25805866.
Copy Download .nbib Format: NLM
Diabetic Retinopathy: A Position Statement by the American Diabetes Association.

Diabetes care

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW.
PMID: 28223445
Diabetes Care. 2017 Mar;40(3):412-418. doi: 10.2337/dc16-2641.

No abstract available.

Cite
Solomon SD, Chew E, Duh EJ, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412-418doi: 10.2337/dc16-2641.
Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017). Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes care, 40(3), 412-418. https://doi.org/10.2337/dc16-2641
Solomon, Sharon D, et al. "Diabetic Retinopathy: A Position Statement by the American Diabetes Association." Diabetes care vol. 40,3 (2017): 412-418. doi: https://doi.org/10.2337/dc16-2641
Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Mar;40(3):412-418. doi: 10.2337/dc16-2641. PMID: 28223445; PMCID: PMC5402875.
Copy Download .nbib Format: NLM
Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178.

Diabetes care

Balkau B, Soulimane S, Simon D, Herman WH.
PMID: 28223448
Diabetes Care. 2017 Mar;40(3):e36. doi: 10.2337/dc16-2000.

No abstract available.

Cite
Balkau B, Soulimane S, Simon D, et al. Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178. Diabetes Care. 2017;40(3):e36doi: 10.2337/dc16-2000.
Balkau, B., Soulimane, S., Simon, D., & Herman, W. H. (2017). Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178. Diabetes care, 40(3), e36. https://doi.org/10.2337/dc16-2000
Balkau, Beverley, et al. "Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178." Diabetes care vol. 40,3 (2017): e36. doi: https://doi.org/10.2337/dc16-2000
Balkau B, Soulimane S, Simon D, Herman WH. Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178. Diabetes Care. 2017 Mar;40(3):e36. doi: 10.2337/dc16-2000. PMID: 28223448.
Copy Download .nbib Format: NLM
Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.

Diabetes care

Misaghian-Xanthos N, Shariff AI, Mekala K, Fearrington LR, Setji TL, Aloi JA, Buse JB.
PMID: 28351898
Diabetes Care. 2017 Jun;40(6):e65-e66. doi: 10.2337/dc16-2591. Epub 2017 Mar 28.

No abstract available.

Cite
Misaghian-Xanthos N, Shariff AI, Mekala K, et al. Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions. Diabetes Care. 2017;40(6):e65-e66doi: 10.2337/dc16-2591.
Misaghian-Xanthos, N., Shariff, A. I., Mekala, K., Fearrington, L. R., Setji, T. L., Aloi, J. A., & Buse, J. B. (2017). Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions. Diabetes care, 40(6), e65-e66. https://doi.org/10.2337/dc16-2591
Misaghian-Xanthos, Negin, et al. "Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions." Diabetes care vol. 40,6 (2017): e65-e66. doi: https://doi.org/10.2337/dc16-2591
Misaghian-Xanthos N, Shariff AI, Mekala K, Fearrington LR, Setji TL, Aloi JA, Buse JB. Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions. Diabetes Care. 2017 Jun;40(6):e65-e66. doi: 10.2337/dc16-2591. Epub 2017 Mar 28. PMID: 28351898; PMCID: PMC5439416.
Copy Download .nbib Format: NLM
Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, Ghosh S, Sanyal D, Hirsch LJ, Gupta V, Strauss KW.
PMID: 28289892
Diabetes Ther. 2017 Jun;8(3):659-672. doi: 10.1007/s13300-017-0244-9. Epub 2017 Mar 13.

INTRODUCTION: Using the Indian and rest of world (ROW) injection technique questionnaire (ITQ) data, we address key insulin injection complications.METHODS: In 2015 we conducted an ITQ survey throughout India involving 1011 patients. Indian values were compared with those from...

Cite
Kalra S, Mithal A, Sahay R, et al. Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional. Diabetes Ther. 2017;8(3):659-672doi: 10.1007/s13300-017-0244-9.
Kalra, S., Mithal, A., Sahay, R., John, M., Unnikrishnan, A. G., Saboo, B., Ghosh, S., Sanyal, D., Hirsch, L. J., Gupta, V., & Strauss, K. W. (2017). Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(3), 659-672. https://doi.org/10.1007/s13300-017-0244-9
Kalra, Sanjay, et al. "Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,3 (2017): 659-672. doi: https://doi.org/10.1007/s13300-017-0244-9
Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, Ghosh S, Sanyal D, Hirsch LJ, Gupta V, Strauss KW. Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional. Diabetes Ther. 2017 Jun;8(3):659-672. doi: 10.1007/s13300-017-0244-9. Epub 2017 Mar 13. PMID: 28289892; PMCID: PMC5446373.
Copy Download .nbib Format: NLM
Richard R. Rubin, PhD: An Ambassador for Behavioral Science in Diabetes.

Diabetes care

Peyrot M.
PMID: 28325793
Diabetes Care. 2017 Apr;40(4):435-439. doi: 10.2337/dc16-1764.

No abstract available.

Cite
Peyrot M. Richard R. Rubin, PhD: An Ambassador for Behavioral Science in Diabetes. Diabetes Care. 2017;40(4):435-439doi: 10.2337/dc16-1764.
Peyrot, M. (2017). Richard R. Rubin, PhD: An Ambassador for Behavioral Science in Diabetes. Diabetes care, 40(4), 435-439. https://doi.org/10.2337/dc16-1764
Peyrot, Mark. "Richard R. Rubin, PhD: An Ambassador for Behavioral Science in Diabetes." Diabetes care vol. 40,4 (2017): 435-439. doi: https://doi.org/10.2337/dc16-1764
Peyrot M. Richard R. Rubin, PhD: An Ambassador for Behavioral Science in Diabetes. Diabetes Care. 2017 Apr;40(4):435-439. doi: 10.2337/dc16-1764. PMID: 28325793.
Copy Download .nbib Format: NLM
Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis.

Diabetes care

Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T.
PMID: 29449311
Diabetes Care. 2018 Apr;41(4):e52-e55. doi: 10.2337/dc17-2095. Epub 2018 Feb 15.

No abstract available.

Cite
Yamada T, Shojima N, Noma H, et al. Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 2018;41(4):e52-e55doi: 10.2337/dc17-2095.
Yamada, T., Shojima, N., Noma, H., Yamauchi, T., & Kadowaki, T. (2018). Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis. Diabetes care, 41(4), e52-e55. https://doi.org/10.2337/dc17-2095
Yamada, Tomohide, et al. "Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis." Diabetes care vol. 41,4 (2018): e52-e55. doi: https://doi.org/10.2337/dc17-2095
Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 2018 Apr;41(4):e52-e55. doi: 10.2337/dc17-2095. Epub 2018 Feb 15. PMID: 29449311.
Copy Download .nbib Format: NLM
Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Wang X, Chen J, Liu X, Gao F, Zhao H, Han D, Jing X, Liu Y, Cui Z, Li C, Ma J.
PMID: 29094299
Diabetes Ther. 2017 Dec;8(6):1379-1392. doi: 10.1007/s13300-017-0327-7. Epub 2017 Nov 01.

INTRODUCTION: Lifestyle behaviors are essential elements of diabetes care. The aims of this study were to identify distinct subgroups of people with type 2 diabetes based on personal levels of lifestyle behaviors and explore the different characteristics across these...

Cite
Wang X, Chen J, Liu X, et al. Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis. Diabetes Ther. 2017;8(6):1379-1392doi: 10.1007/s13300-017-0327-7.
Wang, X., Chen, J., Liu, X., Gao, F., Zhao, H., Han, D., Jing, X., Liu, Y., Cui, Z., Li, C., & Ma, J. (2017). Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(6), 1379-1392. https://doi.org/10.1007/s13300-017-0327-7
Wang, Xuying, et al. "Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,6 (2017): 1379-1392. doi: https://doi.org/10.1007/s13300-017-0327-7
Wang X, Chen J, Liu X, Gao F, Zhao H, Han D, Jing X, Liu Y, Cui Z, Li C, Ma J. Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis. Diabetes Ther. 2017 Dec;8(6):1379-1392. doi: 10.1007/s13300-017-0327-7. Epub 2017 Nov 01. PMID: 29094299; PMCID: PMC5688992.
Copy Download .nbib Format: NLM
Short-term effectiveness of a culturally tailored educational intervention on foot self-care among type 2 diabetes patients in Morocco.

Journal of clinical & translational endocrinology

Adarmouch L, Elyacoubi A, Dahmash L, El Ansari N, Sebbani M, Amine M.
PMID: 29067251
J Clin Transl Endocrinol. 2017 Feb 09;7:54-59. doi: 10.1016/j.jcte.2017.01.002. eCollection 2017 Mar.

BACKGROUND: Self-management education (SME) is an important yet unacknowledged aspect of diabetes care. Despite the raise of diabetes and its complications with significant burden in developing countries, research on SME interventions in Morocco is lacking.AIMS: To assess the effectiveness...

Cite
Adarmouch L, Elyacoubi A, Dahmash L, et al. Short-term effectiveness of a culturally tailored educational intervention on foot self-care among type 2 diabetes patients in Morocco. J Clin Transl Endocrinol. 2017;7:54-59doi: 10.1016/j.jcte.2017.01.002.
Adarmouch, L., Elyacoubi, A., Dahmash, L., El Ansari, N., Sebbani, M., & Amine, M. (2017). Short-term effectiveness of a culturally tailored educational intervention on foot self-care among type 2 diabetes patients in Morocco. Journal of clinical & translational endocrinology, 754-59. https://doi.org/10.1016/j.jcte.2017.01.002
Adarmouch, Latifa, et al. "Short-term effectiveness of a culturally tailored educational intervention on foot self-care among type 2 diabetes patients in Morocco." Journal of clinical & translational endocrinology vol. 7 (2017): 54-59. doi: https://doi.org/10.1016/j.jcte.2017.01.002
Adarmouch L, Elyacoubi A, Dahmash L, El Ansari N, Sebbani M, Amine M. Short-term effectiveness of a culturally tailored educational intervention on foot self-care among type 2 diabetes patients in Morocco. J Clin Transl Endocrinol. 2017 Feb 09;7:54-59. doi: 10.1016/j.jcte.2017.01.002. eCollection 2017 Mar. PMID: 29067251; PMCID: PMC5651287.
Copy Download .nbib Format: NLM
Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy.

Diabetes care

Morrison FJR, Movassaghian M, Seely EW, Curran A, Shubina M, Morton-Eggleston E, Zera CA, Ecker JL, Brown FM, Turchin A.
PMID: 28606900
Diabetes Care. 2017 Jul;40(7):e77-e79. doi: 10.2337/dc17-0186.

No abstract available.

Cite
Morrison FJR, Movassaghian M, Seely EW, et al. Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy. Diabetes Care. 2017;40(7):e77-e79doi: 10.2337/dc17-0186.
Morrison, F. J. R., Movassaghian, M., Seely, E. W., Curran, A., Shubina, M., Morton-Eggleston, E., Zera, C. A., Ecker, J. L., Brown, F. M., & Turchin, A. (2017). Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy. Diabetes care, 40(7), e77-e79. https://doi.org/10.2337/dc17-0186
Morrison, Fritha J R, et al. "Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy." Diabetes care vol. 40,7 (2017): e77-e79. doi: https://doi.org/10.2337/dc17-0186
Morrison FJR, Movassaghian M, Seely EW, Curran A, Shubina M, Morton-Eggleston E, Zera CA, Ecker JL, Brown FM, Turchin A. Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy. Diabetes Care. 2017 Jul;40(7):e77-e79. doi: 10.2337/dc17-0186. PMID: 28606900; PMCID: PMC5481983.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 3020 entries